#molecular diagnostic market size

[market-spy]

Molecular Diagnostics Market to Reach USD 37 Billion by 2031, Growing at 11.4% CAGR | SkyQuest Technology

SkyQuest projects that the Global Molecular Diagnostics Market will attain a value of USD 37.00 Billion by 2031, with a CAGR of 11.4% during the forecast period (2024-2031). The global molecular diagnostics market is a continuously expanding and evolving sector that includes a diverse set of technologies, techniques, and applications for detecting, evaluating, and monitoring diseases at the molecular level. It entails the utilization of nucleic acid-based tests, like polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarrays, to detect genetic variations, mutations, and biomarkers related to a variety of diseases, such as infectious diseases, cancer, and genetic disorders. The market has been impacted by a number of factors, including the rising prevalence of chronic and infectious diseases, increasing demand for personalized medication, advances in genomes and proteomics research, and a requirement for efficient and precise diagnostic tools. The rise of targeted medicines and the move to precision medicine have increased demand for molecular diagnostics, which give critical information for medical care and monitoring. Download a detailed overview: https://www.skyquestt.com/sample-request/molecular-diagnostics-market

Browse in-depth TOC on the "Global Molecular Diagnostics Market" 

Pages - 157 

Tables - 61

Figures – 75

Rising Adoption of PCR is Driving the Molecular Diagnostics Market Growth

PCR is widely employed in CROs, research institutes, and hospitals, which boosts molecular diagnostics market growth rates. The increasing usage of high-throughput PCR technology for detecting viral and genetic illnesses is expected to drive market expansion. For example, Seegene introduced the Allplex SARS-CoV-2 Fast PCR Assay in 2022. The test has a 60-minute turnaround time, making it suited for mass testing. As a result, this component promotes market growth.

High Demand for Personalized Medicine is Boosting the Molecular Diagnostics Market

The increasing demand for personalized medication is a significant driver of the global molecular diagnostics market. Personalized medicine is the practice of personalizing medical therapies and treatments to individual patients depending on genetics, molecular traits, and other relevant criteria. Molecular diagnostics is essential for providing personalized therapy by delivering accurate and targeted information about a patient's ailment, prognosis, and treatment response. The growing understanding of personalized medicine's advantages for enhancing patient outcomes and managing healthcare resources has fuelled demand for molecular diagnostics, resulting in market growth.

Well-Established Healthcare Structure is Driving the Molecular Diagnostics Market of North America North America is the leading region in the global molecular diagnostics market. This is due to factors like a well-established healthcare infrastructure, robust R&D skills, excellent laboratory facilities, and attractive reimbursement rules. The region also has an extensive use of modern diagnostic technologies, such as molecular diagnostics, which is fuelled by the presence of important market participants, the rising frequency of chronic diseases, and an emphasis on unique therapy. The Asia Pacific region is experiencing the most rapid expansion in the global molecular diagnostics market. It is due to rapid expansion like rising healthcare spending, increased knowledge of the benefits of early disease detection, improved access to advanced diagnostic tools, and increased investment in hospital infrastructure.

Molecular Diagnostics Market Insights

Drivers:

Increasing demand for personalized medicine that focuses on tailoring medical treatment is driving the molecular diagnostics market

Rise in elderly population that increases diseases like neurological disorders, diabetes, and obesity

High usage of PCR to identify infectious diseases

Restraints:

Strict regulatory framework can restrict the market growth as inaccurate results due to faulty diagnostic kits can cause issue

Regional and healthcare system reimbursement rules and coverage for molecular diagnostic tests can hinder market penetration and adoption

Molecular diagnostics involve advanced technologies making them expensive

Prominent Market Players of Global Molecular Diagnostics Market

Danaher (US)

F. Hoffmann-La Roche Ltd. (Switzerland)

Hologic, Inc. (US)

Abbott Laboratories (US)

Illumina, Inc. (US)

Thermo Fisher Scientific Inc. (US)

bioMérieux SA (France)

QIAGEN (Netherlands)

Agilent Technologies Inc. (US)

Becton Dickinson And Company (US)

Grifols S.A. (Spain)

Key Questions Answered in the Global Molecular Diagnostics Report

What are the primary drivers of the molecular diagnostics market?

Which are the top companies in the molecular diagnostics market?

Which product segment is leading the global molecular diagnostics market?

What are the challenges restricting the growth of the molecular diagnostics market?

This report provides the following insights:

Analysis of key drivers (Increasing demand for personalized medicine, rise in elderly population, and high usage of PCR), restraints (Different regional and healthcare system reimbursement and high expense of technologies used in molecular diagnostics), opportunities (Increasing adoption of next generation sequencing technologies and rising prevalence of chronic and infectious diseases), and challenges (strict regulatory framework) influencing the growth of molecular diagnostics market

Market Penetration: Comprehensive information on the product offered by the top players in the molecular diagnostics market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the molecular diagnostics market

Market Development: Comprehensive information on emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology. 

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

SkyQuest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

[luckydige45]

According to Nova one advisor, the global molecular diagnostics market size was valued at USD 43.09 billion in 2023 and is projected to reach USD 63.17 billion by 2033, registering a CAGR of 3.9% from 2024 to 2033. The U.S. molecular diagnostics industry size was valued at USD 14.02 billion in 2023.

[renubresearch]

United States Molecular Diagnostics Market will be US$ 541.0 Billion by 2032

United States Molecular Diagnostics Industry Analysis The market for molecular diagnostics in the United States was valued at US$ 7.98 billion in 2023. It is projected to grow to US$ 14.01 billion by 2032, with a compound annual growth rate (CAGR) of 6.46% from 2024 to 2032. Molecular diagnostics is a crucial field that involves the identification of genetic variations to assist in the…

[alicetleibowitz]

Discover the transformative potential of Molecular Diagnostics, where precision meets healthcare, shaping personalized treatment pathways and revolutionizing disease detection.

[marketreports-blog]

The U.S. point-of-care molecular diagnostics market size was valued at USD 4.90 billion in 2023 and is anticipated to reach around USD 5.86 billion by 2033, growing at a CAGR of 1.8 % from 2024 to 2033.

[soumyafwr]

PCR and Real-time PCR Molecular Diagnostics Market Size, Analysis and Forecast 2031

[love-sahil]

Point of Care Molecular Diagnostics Market Partnering Deals of Key Players 2023 - 2028

The Insight Partners proudly announces the release of the latest market research on “Global Point of Care Molecular Diagnostics Market | Size, Share, Statistics, and Forecast” . This trailblazer market research aims to present unparalleled insights into the Point of Care Molecular Diagnostics market. This report presents the current market scenario and attempts to forecast future market size, share, and opportunities for businesses.

This analysis is our commitment to deliver strategic business insights to companies willing to strive in competitive dynamic market space. The Insight Partners covered all dynamics of the Point of Care Molecular Diagnostics market including key trends, challenges, and several opportunities that businesses might have in the future.

Global Point of Care Molecular Diagnostics Market Outlook

This chapter covers several variables that affect business. Future expectations for the Point of Care Molecular Diagnostics market are combined with the economies of scale delineated by market size, growth rate, and compound annual growth rate. To examine demand drivers and constraints before other market actors, this chapter is even more crucial. Companies may better manage their goods and place themselves in the market gap by understanding market trends.

Analysis of the business environment based on several models is provided in this section. Businesses must streamline their success and income streams to be competitive in the Point of Care Molecular Diagnostics industry. Businesses may map the economic, environmental, and legal issues and update their unique selling propositions.

Business Impact of Covid-19

Travel restrictions during COVID-19 led to a decline in sales and supply chain metrics resulted in budget cuts. Many manufacturers had to put projects on hold and companies struggled to recover their fixed costs in the absence of revenue streams. Dealing with sharp decline and managing supply-demand equilibrium Point of Care Molecular Diagnostics market players responded to the new normal. Through this section, Insight Partners attempts to present an analysis of the impact of Covid-19 on business operations.

Market Segmentation

Based on Product & Services of Point of Care Molecular Diagnostics Market Research report:

Assays and Kits

Instruments

and Services and Software

Based on Technology of Point of Care Molecular Diagnostics Market Research report:

PCR

Isothermal Nucleic Acid Amplification Technology (INAAT)

and Other Technologies

Based on Application of Point of Care Molecular Diagnostics Market Research report:

Infectious Diseases

Oncology

Hematology

Prenatal Testing

Endocrinology

and Other Applications

Based on End User of Point of Care Molecular Diagnostics Market Research report:

Hospitals and Clinics

Diagnostic Laboratories

Research and Academic Institutes

and Others

Based on Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World…

Competitive Landscape

This section of the report offers an overview of key Point of Care Molecular Diagnostics market players- bioM?rieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, binx health, Inc., Meridian BioScience, Inc., Biocartis, Quidel Corporation, Bio-Rad Laboratories, Inc.. This chapter further covers details on their strategic approach and market share. Learning about the competition matrix is highly recommended for new entrants in the Point of Care Molecular Diagnostics market, they can strategize success with details on market benchmarks.

Summary:

Market Size & Forecast by Revenue | Forecast Year

Market Dynamics – Market trends, growth drivers, restraints, and investment opportunities

Market Segmentation – Segments based on types, end-users, applications, and key regions

Competitive Landscape – Key market players and their strategies

Strategic Recommendations The Insight Partners presents actionable insights to empower businesses in making informed decisions based on industry evidence. These lucrative suggestions intend to offer our clients a competitive edge over their competitors.

[pragatisblogs]

Molecular Diagnostics Market Size to Grow with High CAGR during Forecast Period

Molecular Diagnostics Market Growth:

Washington, D.C., United States: Straits Research's latest report on, Molecular Diagnostics Market - Global Industry Overview and Forecast 2022-2030, highlights potential, risk factor analyses, and enhanced with strategic and tactical decision-making assistance. The growth and regulatory factors impacting information consumption, the availability of highly dependable items in the market, and the improvement in operating efficiency of Molecular Diagnostics industry players. According to the Straits Research, Molecular Diagnostics Market Size Anticipated to grow at a higher CAGR During the Forecast Period.Molecular Diagnostics Market Scope report covers market trends and development, drivers, capacities, technologies, and the changing dynamics of the Molecular Diagnostics Market.

Competitive Landscape

Some of the prominent players operating in the Molecular Diagnostics market are Abbott Laboratories, Agilent Technologies, Siemens AG, Biomérieux Sa, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Illumina, Roche Diagnostics, Hologic, and Qiagen

Get Free Request Sample Report @ https://straitsresearch.com/report/molecular-diagnostics-market/request-sample

Studies explore the effects of COVID-19 on the upstream, midstream, and downstream sectors of the industry. In addition, this analysis provides extensive market estimations by putting an emphasis on data covering numerous factors that encompass market dynamics such as market drivers, market barriers, market opportunities, market risks, and industry news and trends.

This research also provides a dashboard view of prominent Organization, highlighting their effective marketing tactics, market share and most recent advances in both historical and current settings.

Global Molecular Diagnostics Market: Segmentation

As a result of the Molecular Diagnostics market segmentation, the market is divided into sub-segments based on product type, application, as well as regional and country-level forecasts.

By Product & Service

Reagents & Kits

Instruments

Software & Services

By Technology

Polymerase Chain Reaction (PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

DNA Sequencing & Next-Generation Sequencing (NGS)

In Situ Hybridization

DNA Microarray

Other Technologies

By Application

Infectious Diseases

Hepatitis

HIV

CT/NG

HAIS

HPV

Tuberculosis

Influenza

Other Infectious Diseases

Oncology

Breast Cancer

Colorectal Cancer

Lung Cancer

Prostate Cancer

Other Cancers

Genetic Tests

Other Applications

By End-User

Hospital & Academic Laboratories

Reference Laboratories

Other End Users

Stay ahead of the competition with our in-depth analysis of the market trends!

Buy Now @ https://straitsresearch.com/buy-now/molecular-diagnostics-market

The following are the report's key features:

It gives useful information on the Global Molecular Diagnostics Market.

Information for the years 2022-2030 is provided.

Market-related important factors are highlighted.

The latest technological innovations, government restrictions, and developments are presented.

This paper investigates advertising and marketing techniques, market trends, and analysis.

Growth projections and analyses by forecast 2030.

The statistical analysis of the market's leading competitors is emphasised.

Molecular Diagnostics Market summary based on extensive study.

Other aspects of the report include:

Provides a complete review of important tactics in numerous firms, with an emphasis on corporate structure, R&D processes, localization strategies, manufacturing capabilities, sales, and performance.

Provides essential product portfolio information, including product planning, development, and positioning.

Analyzes the role of significant market participants, as well as their collaborations, mergers, and acquisitions.

Trending Report:

About Straits Research

Straits Research is dedicated to providing businesses with the highest quality market research services. With a team of experienced researchers and analysts, we strive to deliver insightful and actionable data that helps our clients make informed decisions about their industry and market. Our customized approach allows us to tailor our research to each client's specific needs and goals, ensuring that they receive the most relevant and valuable insights.

Contact Us

Email: sales@straitsresearch.com 

Address: 825 3rd Avenue, New York, NY, USA, 10022

Tel: +1 6464807505, +44 203 318 2846

[luckydige45]

According to Nova One Advisor, the global molecular diagnostics market size was exhibited at USD 43.09 billion in 2023 and is projected to hit around USD 63.17 billion by 2033, growing at a CAGR of 3.9% during the forecast period 2024 to 2033.

[bisresearchreports]

The growth in the global molecular oncology diagnostics market is expected to be driven by the rising prevalence of cancers and increased transformations in biomarker identification.

[renubresearch]

Global Molecular Diagnostics Market will be US$ 26.27 Billion by 2032

Global Molecular Diagnostics Market Analysis The Global Molecular Diagnostics Market is not just a growing market, but a market with immense potential. It is projected to exceed US$26.27 billion by 2032, showing a significant leap from its 2023 value of US$11.88 billion. The compound annual growth rate (CAGR) from 2024 to 2032 is estimated to be a promising 9.21%. Molecular diagnostics is not…

[sanpdr1994]

Point-of-care Molecular Diagnostics Market Sales, Revenue and Market Share by Regions Analysis and Forecasts to 2032

Per the point-of-care molecular diagnostics market survey by Future Market Insights (FMI), the market is forecasted to move forward at an average pace and register a CAGR of 8% from 2022 to 2032.

Many current POC diagnostics are based on lateral flow immunoassay technology, and these instruments use antibodies to detect the presence of an analyte, such as cancer biomarkers, in a short period and thus, having the effect of spurring the point-of-care molecular diagnostics market growth to a large extent. As per the point-of-care molecular diagnostics market report, the demand for point-of-care molecular diagnostics is on a surge owing to the growing trend toward preventive medicine. This is considered to shape the point-of-care molecular diagnostics future trends to a large extent.

According to United Nations data, the number of older adults has steadily increased for decades. As a result of this demographic shift, the prevalence of various chronic diseases is rising, thereby facilitating the adoption of point-of-care molecular diagnostics devices. The study finds that current cancer diagnostic methods are invasive (for example, cystoscopy, which involves inserting a hollow tube/cystoscope installed with a lens into the urethra and bladder to diagnose cancer). However, less invasive methods, such as point-of-care molecular tests, can be available for point-of-care cancer diagnostics, broadening the point-of-care molecular diagnostics opportunities.

Though most of the industries’ overall sales of molecular diagnostics dwindled steeply due to the COVID-19 pandemic and the use of molecular diagnostic methods for COVID-19 testing, it had a positive impact on the point-of-care molecular diagnostics market size. As countries gradually slacken their restrictions on movement, there is a resurgence in testing numbers. Aside from vaccines and therapeutic drugs, there is an increasing demand for the development of more precise and simple testing technologies and the expansion of testing structures.

Key Takeaways

The assays and kits segment is expected to account for a significant chunk of the POC molecular diagnostics market based on the product type. The market growth of this segment is being driven by the widespread purchase of these products’ POC diagnostic devices as a result of their frequent usage. The RT-PCR segment is expected to dominate the point-of-care molecular diagnostics market in terms of technology, owing to the increasing use of RT-PCR in proteomics, genomics, and COVID-19 testing and the availability of portable, easy-to-use POC devices.

The respiratory diseases segment is projected to lead the POC molecular diagnostics market on account of the shift of concentration by key players on various strategies for developing advanced point-of-care diagnostics devices.

By end-use, the hospital bedside segment is expected to witness the most significant point-of-care molecular diagnostics market share due to the rising adoption of advanced instruments in these settings and rapid investments in hospital infrastructure by the public and private sectors in emerging countries. The Asia Pacific region is expected to proliferate due to the expansion of key market players, a lack of sophisticated central laboratory point-of-care molecular testing services, and the potential cost-effectiveness of POC molecular diagnosis.

“The North American market is expected to be at the forefront of the point-of-care molecular diagnostics market, attributable to the United States’ emerging trends in point-of-care molecular diagnostics market such as well-organized health-care system. In addition, the system promotes research and development. These policies encourage foreign players to enter the United States and the North American market. As a result, many global market players are present in this region, and the market is projected to flourish as high demand is met by the presence of global players in the region.” opines an FMI researcher.

Competitive Landscape

The top point-of-care diagnostics companies are developing most point-of-care molecular diagnostic tests and have established their market position by investing more in research and developing a better distribution system.

The entry of new players challenges the semi-consolidated market and may result in intense competition during the forecast period.

Furthermore, due to increased awareness, the Asia-Pacific region is seeing the emergence of some minor players, which aided the point-of-care molecular diagnostics market growth.

Danaher Corporation (US), Alere Inc. (US), Quidel Corporation (US), Biocartis Group NV (Belgium), bioMérieux SA (France), Thermo Fisher Scientific (US), Mesa Biotech Inc. (US), F. Hoffmann-La Roche Ltd., and Meridian Bioscience Inc. (US) are the critical point-of-care diagnostic companies profiled in the global POC molecular diagnostics market.

Recent developments in the point-of-care molecular diagnostics market are as follows:

The World Health Organization (WHO), Africa Centers for Disease Control and Prevention (Africa CDC), the Bill & Melinda Gates Foundation, the Clinton Health Access Initiative (CHAI), the Foundation for Innovative New Diagnostics (FIND), and the Global Fund constituted a global partnership. Today, the organization announced the launch of the COVID-19 rapid test in low and middle-income countries. Mylab Discovery Solutions has collaborated with Hemex Health, the United States company, to develop next-generation diagnostic solutions for coronavirus and another point-of-care diagnostic testing.

Point-of-care Molecular Diagnostics Market Key Segments

By Product & Service:

Assays & kits Instruments & Analyzers Software & Services

By Technology:

RT-PCR INAAT Other technologies

By Application:

Respiratory Diseases Sexually Transmitted Diseases Hospital-acquired Infections Cancer Hepatitis Gastrointestinal Disorders Other Applications

By End User:

Physicians’ Offices Hospitals & ICUs Research Institutes Other End Users

[marketreports-blog]

The global oncology molecular diagnostic market is valued at USD 2.45 billion in 2023 and is projected to reach a value of USD 7.71 Billion by 2032 at a CAGR (Compound Annual Growth Rate) of 12.20% between 2024 and 2033

[soumyafwr]

PCR and Real-time PCR Molecular Diagnostics Market Size, Analysis and Forecast 2031